Nasdaq · Common stock
Kailera Therapeutics (KLRA)
$12.77 −$0.08 (−0.62%)
- Day’s range
- $12.62–$13.14
- Volume
- 588,890
KLRA price history
KLRA closed at $12.77 on Oct. 26, 2026. Over the past year, its daily close ranged from $10.00 on Oct. 8, 2026 to $26.00 on April 17, 2026.
Data table: KLRA daily closes, the past year
| Date | Close |
|---|---|
| Oct. 26, 2026 | $12.77 |
| Oct. 23, 2026 | $12.85 |
| Oct. 22, 2026 | $13.27 |
| Oct. 21, 2026 | $12.92 |
| Oct. 20, 2026 | $12.89 |
| Oct. 19, 2026 | $11.43 |
| Oct. 16, 2026 | $11.25 |
| Oct. 15, 2026 | $11.71 |
| Oct. 14, 2026 | $10.74 |
| Oct. 13, 2026 | $10.77 |
| Oct. 12, 2026 | $11.33 |
| Oct. 9, 2026 | $11.61 |
| Oct. 8, 2026 | $10.00 |
| Oct. 7, 2026 | $10.53 |
| Oct. 6, 2026 | $10.83 |
| Oct. 5, 2026 | $10.84 |
| Oct. 2, 2026 | $10.39 |
| Oct. 1, 2026 | $11.03 |
| Sept. 30, 2026 | $11.42 |
| Sept. 29, 2026 | $10.99 |
| Sept. 28, 2026 | $11.12 |
| Sept. 25, 2026 | $11.22 |
| Sept. 24, 2026 | $11.98 |
| Sept. 23, 2026 | $13.13 |
| Sept. 22, 2026 | $12.79 |
| Sept. 21, 2026 | $11.99 |
| Sept. 18, 2026 | $12.83 |
| Sept. 17, 2026 | $12.92 |
| Sept. 16, 2026 | $12.70 |
| Sept. 15, 2026 | $13.45 |
| Sept. 14, 2026 | $13.75 |
| Sept. 11, 2026 | $13.94 |
| Sept. 10, 2026 | $14.91 |
| Sept. 9, 2026 | $14.84 |
| Sept. 8, 2026 | $16.43 |
| Sept. 4, 2026 | $16.23 |
| Sept. 3, 2026 | $15.74 |
| Sept. 2, 2026 | $15.85 |
| Sept. 1, 2026 | $16.41 |
| Aug. 31, 2026 | $15.40 |
| Aug. 28, 2026 | $16.21 |
| Aug. 27, 2026 | $18.53 |
| Aug. 26, 2026 | $18.44 |
| Aug. 25, 2026 | $17.75 |
| Aug. 24, 2026 | $16.54 |
| Aug. 21, 2026 | $17.17 |
| Aug. 20, 2026 | $17.46 |
| Aug. 19, 2026 | $18.32 |
| Aug. 18, 2026 | $17.83 |
| Aug. 17, 2026 | $18.51 |
| Aug. 14, 2026 | $17.94 |
| Aug. 13, 2026 | $17.97 |
| Aug. 12, 2026 | $18.59 |
| Aug. 11, 2026 | $18.87 |
| Aug. 10, 2026 | $18.98 |
| Aug. 7, 2026 | $18.66 |
| Aug. 6, 2026 | $18.87 |
| Aug. 5, 2026 | $18.17 |
| Aug. 4, 2026 | $18.11 |
| Aug. 3, 2026 | $17.32 |
| July 31, 2026 | $16.94 |
| July 30, 2026 | $17.05 |
| July 29, 2026 | $16.88 |
| July 28, 2026 | $16.74 |
| July 27, 2026 | $17.48 |
| July 24, 2026 | $17.69 |
| July 23, 2026 | $17.40 |
| July 22, 2026 | $17.79 |
| July 21, 2026 | $18.41 |
| July 20, 2026 | $17.91 |
| July 17, 2026 | $18.55 |
| July 16, 2026 | $18.32 |
| July 15, 2026 | $19.30 |
| July 14, 2026 | $19.01 |
| July 13, 2026 | $19.97 |
| July 10, 2026 | $20.68 |
| July 9, 2026 | $21.01 |
| July 8, 2026 | $21.76 |
| July 7, 2026 | $22.24 |
| July 6, 2026 | $23.30 |
| July 2, 2026 | $21.99 |
| July 1, 2026 | $20.82 |
| June 30, 2026 | $22.03 |
| June 29, 2026 | $21.67 |
| June 26, 2026 | $20.83 |
| June 25, 2026 | $20.66 |
| June 24, 2026 | $21.37 |
| June 23, 2026 | $21.37 |
| June 22, 2026 | $22.88 |
| June 18, 2026 | $19.90 |
| June 17, 2026 | $19.13 |
| June 16, 2026 | $18.55 |
| June 15, 2026 | $19.67 |
| June 12, 2026 | $18.89 |
| June 11, 2026 | $19.54 |
| June 10, 2026 | $19.14 |
| June 9, 2026 | $19.64 |
| June 8, 2026 | $19.70 |
| June 5, 2026 | $19.37 |
| June 4, 2026 | $20.99 |
| June 3, 2026 | $22.38 |
| June 2, 2026 | $22.59 |
| June 1, 2026 | $23.18 |
| May 29, 2026 | $22.94 |
| May 28, 2026 | $22.94 |
| May 27, 2026 | $21.91 |
| May 26, 2026 | $21.57 |
| May 22, 2026 | $21.17 |
| May 21, 2026 | $21.08 |
| May 20, 2026 | $20.07 |
| May 19, 2026 | $19.62 |
| May 18, 2026 | $19.55 |
| May 15, 2026 | $21.04 |
| May 14, 2026 | $21.50 |
| May 13, 2026 | $21.11 |
| May 12, 2026 | $22.30 |
| May 11, 2026 | $22.93 |
| May 8, 2026 | $21.47 |
| May 7, 2026 | $22.47 |
| May 6, 2026 | $24.70 |
| May 5, 2026 | $24.26 |
| May 4, 2026 | $25.09 |
| May 1, 2026 | $25.15 |
| April 30, 2026 | $25.00 |
| April 29, 2026 | $24.76 |
| April 28, 2026 | $23.82 |
| April 27, 2026 | $23.51 |
| April 24, 2026 | $22.47 |
| April 23, 2026 | $25.08 |
| April 22, 2026 | $24.30 |
| April 21, 2026 | $25.22 |
| April 20, 2026 | $24.61 |
| April 17, 2026 | $26.00 |
Key figures
- Average daily volume
- 1.0MPast 3 months
- Market value
- $1.66B
- Dividend yield
- —
Price change
- 1 month
- +13.87%
- 3 months
- −27.81%
What Wall Street says about KLRA
No Wall Street firm has published a rating or price-target change on KLRA in the past 90 days.
Ratings and price targets are the firms’ own opinions, reported as published.
Not investment advice.
About Kailera Therapeutics, Inc. Common Stock
Kailera Therapeutics Inc is a clinical-stage biotechnology company. The company focuses on developing a diversified pipeline to provide options for people living with obesity. The company is progressing four clinical-stage product candidates, leveraging multiple GLP-1 based mechanisms of action and routes of administration. The company's obesity-first approach seeks to advance product candidates with the potential to maximize weight loss and address critical needs in the current therapeutic landscape.
- Headquarters
- Waltham, Mass.
- Listed
- April 17, 2026
- Sector
- Health care
- Industry
- Pharmaceutical preparations
In WallStreetDigest editions
No WallStreetDigest article about KLRA is on the site yet.